Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDR”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03742895
What this trial is testing

Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)

Who this might be right for
Advanced Solid Neoplasms
Merck Sharp & Dohme LLC 329
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07300566
What this trial is testing

Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial

Who this might be right for
Prostate Cancer
Joelle Helou 58
Testing effectiveness (Phase 2)WithdrawnNCT06392841
What this trial is testing

Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Deleterious HRR Gene MutationBRCA1 Gene Mutation+7 more
Qian Qin
Testing effectiveness (Phase 2)WithdrawnNCT03432676
What this trial is testing

Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer

Who this might be right for
ATM Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+7 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03025035
What this trial is testing

Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer

Who this might be right for
Breast Cancer
Yuan Yuan 14
Testing effectiveness (Phase 2)UnknownNCT04822961
What this trial is testing

Senaparib in mCRPC Patients With Homologous Recombination Repair Gene Alterations After Docetaxel Treatment

Who this might be right for
mCRPC
Impact Therapeutics, Inc. 285
Not applicableLooking for participantsNCT06200974
What this trial is testing

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

Who this might be right for
Localized Prostate Carcinoma
British Columbia Cancer Agency 100
Not applicableStudy completedNCT00791115
What this trial is testing

Salvage Prostatectomy After Radiotherapy

Who this might be right for
Prostate Cancer
University Health Network, Toronto 16
Not applicableActive Not RecruitingNCT02623933
What this trial is testing

MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Not applicableLooking for participantsNCT05665738
What this trial is testing

Two-fraction HDR Monotherapy for Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaLocalized Prostate Carcinoma
University of California, San Francisco 17
Not applicableActive Not RecruitingNCT01583920
What this trial is testing

Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Testing effectiveness (Phase 2)Looking for participantsNCT04100174
What this trial is testing

Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy

Who this might be right for
Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 150
Not applicableStudy completedNCT01757717
What this trial is testing

Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis

Who this might be right for
Metastatic or Recurrent Lesions in the SpineMetastatic or Recurrent Lesions in the Pelvis
Memorial Sloan Kettering Cancer Center 3
Not applicableActive Not RecruitingNCT02400658
What this trial is testing

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

Who this might be right for
Breast Cancer
Shayna Showalter, MD 358
Early research (Phase 1)Study completedNCT01017640
What this trial is testing

Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors

Who this might be right for
Solid Neoplasm
National Cancer Institute (NCI) 20
Not applicableStudy completedNCT05573789
What this trial is testing

Tumor Molecular Profiling in Patients With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate Adenocarcinoma
Hellenic Cooperative Oncology Group 220
Large-scale testing (Phase 3)Study completedNCT03834519
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 793
Not applicableLooking for participantsNCT05936736
What this trial is testing

24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer

Who this might be right for
Localized Prostate Carcinoma
IRCCS San Raffaele 70
Testing effectiveness (Phase 2)Study completedNCT02873975
What this trial is testing

LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency

Who this might be right for
Advanced Cancers
Dana-Farber Cancer Institute 27
Not applicableLooking for participantsNCT00913939
What this trial is testing

High-Dose-Rate Brachytherapy

Who this might be right for
Patients With Prostate Cancer
University Health Network, Toronto 500
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation